{reportSlug=global-primary-hyperoxaluria-drug-market, reportId=35146, mktKeyword=Primary Hyperoxaluria Drug, cagr=0.00, publishDate=Apr 2021, priceOption2=6500, reportTitle=Primary Hyperoxaluria Drug Comprehensive Study by Type (ALLN-230, DCR-PHXC, ALN-GO1, Others), Application (Hospital, Clinic, Others), Drug types (Primary hyperoxaluria type III (PH III), Primary hyperoxaluria type II (PH II), Primary hyperoxaluria type I (PH I)) Players and Region - Global Market Outlook to 2026, baseYr=2021, totalTableFig=200, priceOption1=3450, forecastYr=2027, noOfPages=219, reportKey=34880, breadcrum=Global Primary Hyperoxaluria Drug}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Apr 2021 219 Pages 60 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner